仿生眼市场 - 按眼睛类型、技术、适应症、最终用途 - 全球预测，2024 年 - 2032 年

由于技术进步和客製化选项的可用性，2024 年至 2032 年间，全球仿生眼市场规模将以 11.6% 的复合年增长率成长。

随着微电子和机器人技术的不断创新，仿生眼提供了改进的视觉能力。此外，患者现在可以为其植入物提供多种客製化选项，包括颜色选择和设计。这种个人化提高了患者满意度并鼓励采用。随着意识的增强和越来越多的人寻求增强的视觉解决方案，先进技术和客製化的结合将推动仿生眼产业的显着扩张。例如，2023 年 8 月，HumanOptics 推出了一种新型优质虹膜植入物，透过为患者量身定制的创新选项扩大了其颜色选择范围。

仿生眼市场根据眼睛类型、技术、适应症、最终用途和地区进行细分。

由于机械仿生眼的强劲性能和长期可靠性，到 2032 年，机械细分市场将呈现健康的成长速度。凭藉其耐用且经过验证的设计，机械仿生眼为视力恢復提供了稳定的选择。随着生物力学的进步不断提高机械植入物的功能和寿命，它们仍然是患者和临床医生的热门选择。机械领域专注于提供可靠且有效的视觉解决方案，将占据重要的仿生眼市场。

由于眼科诊所在提供和促进这些先进视觉修復术的采用方面发挥关键作用，眼科诊所部分将在 2024 年至 2032 年期间获得显着增长。这些诊所是仿生眼植入手术、病人咨询和术后护理的重要中心。眼科诊所专注于眼睛健康和视力恢復，并处于仿生眼创新的前沿。他们的专业知识、专业设施和全面的患者支援占据了该细分市场的最大份额，满足了对视力增强技术日益增长的需求。

亚太地区仿生眼产业将在 2024 年至 2032 年间呈现显着的复合年增长率，原因是其庞大的人口、不断增加的医疗支出以及视力障碍盛行率的上升。中国和日本等国在仿生眼研发上表现突出。此外，该地区人口老化加剧了对视力恢復技术的需求。由于高度重视医疗保健的进步和可及性，亚太地区将成为仿生眼产业的主要贡献者，反映出其在塑造视觉义肢未来方面的关键作用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 视力丧失和其他慢性眼疾的盛行率不断上升
    • 增加私人和公共组织的资助
    • 科技发展日新月异
  • 产业陷阱与挑战
    • 目标族群认知度低
    • 与这些程序相关的高成本
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按眼睛类型，2018 - 2032

• 主要趋势
• 外眼
• 植入眼

第 6 章：市场估计与预测：按技术划分，2018 年 - 2032 年

• 主要趋势
• 电子的
• 机械的
• 其他技术

第 7 章：市场估计与预测：按指标划分，2018 年 - 2032 年

• 主要趋势
• 视力丧失和障碍
• 色素性视网膜炎
• 干性老年黄斑部病变
• 其他适应症

第 8 章：市场估计与预测：按最终用途分类，2018 年 - 2032 年（百万美元）

• 主要趋势
• 医院
• 眼科诊所
• 其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Bionic Eye Technologies, Inc.
• Bionic Vision Technologies
• iBionics
• Monash Vision Group
• Nidek Co. Ltd.
• Optobionics
• Pixium Vision SA
• Schott
• Second Sight Medical Products, Inc.
• Vivani Medical, Inc.

Global Bionic Eye Market Size will grow at 11.6% CAGR between 2024 and 2032, owing to technological advancements and the availability of customization options.

With ongoing innovations in microelectronics and robotics, bionic eyes offer improved vision capabilities. Moreover, patients now have a wide range of customization options for their implants, including color selection and design. This personalization enhances patient satisfaction and encourages adoption. As awareness grows and more individuals seek enhanced vision solutions, the combination of advanced technology and customization will drive significant expansion in the bionic eye industry. For instance, in August 2023, HumanOptics introduced a novel premium iris implant, expanding its color selection range with innovative options for patients' customization.

The bionic eye market is segmented based on eye type, technology, indication, end-use, and region.

The mechanical segment will exhibit a healthy growth rate through 2032 due to the mechanical bionic eye's robust performance and long-standing reliability. With their durable and proven designs, mechanical bionic eyes offer a stable option for vision restoration. As advancements in biomechanics continue to enhance the functionality and longevity of mechanical implants, they remain a popular choice among patients and clinicians. With a focus on providing dependable and effective vision solutions, the mechanical segment will capture a significant bionic eye market share.

The ophthalmic clinic segment will garner notable gains over 2024-2032, driven by the pivotal role of ophthalmic clinics in providing access to and facilitating the adoption of these advanced visual prosthetics. These clinics serve as essential hubs for bionic eye implantation surgeries, patient consultations, and post-operative care. With a focus on eye health and vision restoration, ophthalmic clinics are at the forefront of bionic eye innovation. Their expertise, specialized facilities, and comprehensive patient support contribute to the segment's largest share, meeting the increasing demand for vision-enhancing technologies.

Asia Pacific bionic eye industry will demonstrate a noteworthy CAGR between 2024 and 2032, driven by its vast population, increasing healthcare expenditure, and rising prevalence of visual impairments. Countries like China and Japan are prominent in bionic eye research and development. Moreover, the region's aging population fuels the demand for vision-restoring technologies. With a significant focus on healthcare advancements and accessibility, Asia Pacific will emerge as the major contributor to the bionic eye industry, reflecting its crucial role in shaping the future of visual prosthetics.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of vision loss and other chronic eye diseases
    • 3.2.1.2 Increasing funding by private and public organizations
    • 3.2.1.3 Rapid advancements in technological developments
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Low awareness among target population
    • 3.2.2.2 High costs associated with these procedures
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Eye Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 External eye
• 5.3 Implanted eye

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Electronic
• 6.3 Mechanical
• 6.4 Other technologies

Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Vision loss and impairment
• 7.3 Retinitis pigmentosa
• 7.4 Dry age-related macular degeneration
• 7.5 Other indications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ophthalmic clinics
• 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Bionic Eye Technologies, Inc.
• 10.2 Bionic Vision Technologies
• 10.3 iBionics
• 10.4 Monash Vision Group
• 10.5 Nidek Co. Ltd.
• 10.6 Optobionics
• 10.7 Pixium Vision SA
• 10.8 Schott
• 10.9 Second Sight Medical Products, Inc.
• 10.10 Vivani Medical, Inc.